---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-122864"
form_type: "8-K"
ticker: "RIGL"
cik: "0001034842"
company_name: "RIGEL PHARMACEUTICALS INC"
filed_at: "2022-11-29T23:59:59+00:00"
generated_at: "2026-06-21T12:03:07.548860+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Rigel Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Nasdaq notified Rigel on Nov 22, 2022 that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Rigel has 180 calendar days, until May 22, 2023, to regain compliance by closing at $1.00 or more for at least 10 consecutive business days.
- If not compliant by May 22, Rigel may be eligible for an additional 180-day period if it meets other listing standards and intends to cure via reverse stock split.
- Failure to regain compliance could lead to delisting; Rigel may appeal a delisting determination.
- No immediate effect on Nasdaq listing; stock continues to trade under RIGL.

## SEC filing metadata
- accession: 0001104659-22-122864
- form_type: 8-K
- ticker: RIGL
- cik: 0001034842
- company_name: RIGEL PHARMACEUTICALS INC
- filed_at: 2022-11-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1034842/000110465922122864/0001104659-22-122864-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1034842/000110465922122864/tm2231482d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-122864
- JSON: https://secwatch.observer/filing/0001104659-22-122864.json
- Plain text: https://secwatch.observer/filing/0001104659-22-122864.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.